Trade Name: Ceftriaxone

Following information is meant for : Wholesalers, Suppliers, Exporters, Doctors, CROs, Comparator Supplies, Hospitals, MOH Tender Supplies, Generic, Brand, Cooperate Sourcing, India, Institutional Buyers.

Manufacturer: Samson Medical Technologies, LLC

Presentation: INJECTION, POWDER, FOR SOLUTION, HUMAN PRESCRIPTION DRUG

Strength: 100 g/1

Storage and handling

CEFTRIAXONE SODIUM Cephalosporin Antibacterial [EPC],Cephalosporins [CS]

Disclaimer:
  1. These products are NOT FOR SALE in US territories. We offer them for Exports outside of US Territories to Trade Professionals or patients with a valid prescription.
  2. Trademark shown are property of their respective owners and GNH India does not lay any claim on them.
  3. Read more
  • No data
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of Ceftriaxone for Injection and other antibacterial drugs, Ceftriaxone for Injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
  • Ceftriaxone for Injection is indicated for the treatment of the following infections when caused by susceptible bacteria:
  • Ceftriaxone for Injection, USP is a cephalosporin antibacterial indicated for the treatment of the following infections caused by susceptible isolates of the designated bacteria: Lower Respiratory Tract Infections (); Skin and Skin Structure Infections (); Complicated and Uncomplicated Urinary Tract Infections (); Pelvic Inflammatory Disease (); Bacterial Septicemia (); Bone and Joint infections (); Intra-abdominal Infections (); Meningitis (); and Surgical Prophylaxis ().
  • Ceftriaxone for Injection USP, Pharmacy Bulk Package bag SmartPak should be used only in patients who require a 1 gram dose and not any fraction thereof.
  • Ceftriaxone for Injection USP, Pharmacy Bulk Package bag SmartPak should not be used in patients who require less than the 1 gram dose of Ceftriaxone.
  • THIS PHARMACY BULK PACKAGE REQUIRES RECONSTITUTION WITH STERILE WATER FOR INJECTION, USP TO A CONCENTRATION OF 100 mg per mL AND FURTHER DILUTION IN 50 mL OF A COMPATIBLE SOLUTION.
  • USE THIS FORMULATION OF CEFTRIAXONE ONLY IN PATIENTS WHO REQUIRE A 1 GRAM DOSE.
  • For intravenous use only over approximately 30 minutes. ()
  • THIS IS A PHARMACY BULK PACKAGE u2013 NOT FOR DIRECT INJECTION.
  • Ceftriaxone for Injection USP, Pharmacy Bulk Package bag SmartPaku00a0should be used only in patients who require a 1 gram dose and not any fraction thereof. Ceftriaxone for Injection USP, Pharmacy Bulk Package bag SmartPak should not be used in patients who require less than the 1 gram dose of ceftriaxone ().
  • Ceftriaxone for Injection USP, Pharmacy Bulk Package bag SmartPaku00ae should be used only in patients who require a 1 gram dose and not any fraction thereof. Ceftriaxone for Injection USP, Pharmacy Bulk Package bag SmartPak should not be used in patients who require less than the 1 gram dose of ceftriaxone. ()
  • Dilution
  • Important Administration Instructions
  • No data
  • Pharmacy Bulk Package bags, 100 grams ()THIS IS A PHARMACY BULK PACKAGE u2013 NOT FOR DIRECT INJECTION
  • Ceftriaxone for Injection, USP is contraindicated in patients who have a history of anaphylaxis to ceftriaxone or the cephalosporin class of antibacterials, penicillins, or other beta-lactam antibacterials [see ].
  • Anaphylaxis to ceftriaxone or other cephalosporin class antibacterials, penicillins or other beta-lactam antibacterials ()
  • No data
  • Hypersensitivity reactions: Include anaphylaxis and serious skin reactions. Cross hypersensitivity may occur in up to 10% of patients with a history of penicillin allergy. If an allergic reaction occurs, discontinue the drug ().n
  • Interaction with Calcium-containing products: Precipitation can occur. Do not administer simultaneously with calcium-containing I.V. solutions ().n
  • Clostridium difficile
  • Hemolytic Anemia: Severe cases of hemolytic anemia, including fatalities in adults and children, have been reported. If anemia is diagnosed, discontinue the drug until the etiology is determined. ()
  • The following serious adverse reactions to ceftriaxone are described below and elsewhere in the labeling:
  • The most common adverse reactions occurring in >2% of patients receiving ceftriaxone include diarrhea, eosinophilia, thrombocytosis, leukopenia, and elevations of SGOT and SGPT. ()
  • No data
  • Vancomycin, amsacrine, aminoglycosides and fluconazole are physically incompatible. ()
  • Calcium-containing products: precipitation can occur. ()
  • No data
  • Hepatic impairment:
  • Renal Impairment: This formulation of Ceftriaxone for Injection USP u2013 Pharmacy Bulk Package bag, SmartPak should not be used in renally impaired patients who require less than the 1 gram dose of ceftriaxone.
  • Pediatric Patients: This formulation of Ceftriaxone for Injection USP u2013 Pharmacy Bulk Package bag, SmartPak should not be used in pediatric patients who require less than the 1 gram adult dose of ceftriaxone.
  • In the case of overdosage, drug concentration would not be reduced by hemodialysis or peritoneal dialysis. There is no specific antidote. Treatment of overdosage should be symptomatic.
  • Ceftriaxone for Injection, USP, Pharmacy Bulk Package bag SmartPak should be used only in patients who require a 1 gram dose and not any fraction thereof.
  • Ceftriaxone for Injection USP, Pharmacy Bulk Package bag SmartPak should not be used in patients who require less than the 1 gram dose of ceftriaxone.
  • Ceftriaxone for Injection, USP, is a sterile, semisynthetic, broad-spectrum cephalosporin antibacterial for intravenous administration. Ceftriaxone sodium is (6,7)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo--triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-()-(O-methyloxime), disodium salt, sesquaterhydrate.
  • The chemical formula of ceftriaxone sodium is CHNNaOSu20223.5HO. It has a calculated molecular weight of 661.60 and the following structural formula:
  • Ceftriaxone sodium is a white to yellowish-orange crystalline powder, which is readily soluble in water, sparingly soluble in methanol and very slightly soluble in ethanol. The H of a 1% aqueous solution is approximately 6.7. The color of ceftriaxone sodium solutions ranges from light yellow to amber, depending on the length of storage and concentration. Each Pharmacy Bulk Package contains approximately 83 mg (3.6 mEq) of sodium per 1 gram of ceftriaxone activity. Ceftriaxone for Injection, USP is supplied in 100 grams SmartPak Pharmacy Bulk Packages bags equivalent. Each SmartPak Pharmacy Bulk Package bag contains ceftriaxone sodium, USP equivalent to 100 grams of ceftriaxone.
  • BEFORE ADMINISTRATION, THIS PHARMACY BULK PACKAGE REQUIRES RECONSTITUTION USING STERILE WATER FOR INJECTION, USP TO A CONCENTRATION OF 100 mg per mL AND FURTHER DILUTION IN 50 mL OF A COMPATIBLE SOLUTION AND INFUSED INTRAVENOUSLY OVER 30 MINUTES.
  • THIS PRODUCT IS NOT INTENDED TO BE USED IN PEDIATRIC PATIENTS AND RENALLY IMPAIRED PATIENTS WHO REQUIRE LESS THAN A 1 GRAM DOSE.
  • A Pharmacy Bulk Package is a container of a sterile preparation for parenteral use that contains many single doses. The contents are intended for use in a pharmacy admixture service and are restricted to the preparation of admixtures for intravenous infusion.
  • No data
  • No data
  • Ceftriaxone for Injection, USP is available in the following SmartPak Pharmacy Bulk Package bags:
  • u00a0u00a0u00a0100 grams*
  • u00a0u00a0u00a0*Each 100 gram Pharmacy Bulk Package bag contains sterile ceftriaxone sodium equivalent to 100 grams of ceftriaxone
  • SmartPak system components are not made with natural rubber latex.
  • Precautions
  • As with other cephalosporins, reconstituted Ceftriaxone for Injection tends to darken depending on storage conditions within the stated recommendations. However, product potency is not adversely affected.
  • Use only if prepared solution is clear and free from particulate matter.
  • Storage Conditions
  • Prior to reconstitution, store Ceftriaxone for Injection sterile powder at room temperature 20u00ba-25u00baC (68u00ba-77u00baF) [see USP Controlled Room Temperature] and protected from light.
  • Patients should be advised that allergic reactions, including serious allergic reactions could occur and that serious reactions require immediate treatment and discontinuation of ceftriaxone. Patients should report to their health care provider any previous allergic reactions to ceftriaxone, cephalosporins, penicillins, or other similar antibacterials.
  • Advise patients of neurological adverse reactions that could occur with Ceftriaxone for Injection, USP use. Instruct patients to inform a healthcare provider at once of any neurological signs and symptoms, including encephalopathy (disturbance of consciousness including confusion, hallucinations, stupor, and coma), myoclonus, and seizures, for immediate treatment, dosage adjustment, or discontinuation of Ceftriaxone for Injection, USP.
  • Patients should be advised that diarrhea is a common problem caused by antibacterials, which usually ends when the antibacterial is discontinued. Sometimes after starting treatment with antibacterials, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as two or more months after having taken the last dose of the antibacterial. If this occurs, patients should contact a physician as soon as possible.
  • Patients should be counseled that antibacterial drugs including ceftriaxone, should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Ceftriaxone for Injection, USP is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by ceftriaxone or other antibacterial drugs in the future.
  • Rx only
  • SmartPak is a registered trademark of Samson Medical Technologies, L.L.C.
  • C6100c
  • Manufactured forn n
  • NDC 66288-n
  • CEFTRIAXONE FOR INJECTION, USP
  • PHARMACY BULK PACKAGE -NOT FOR DIRECT INFUSION
  • 100 grams [ONE HUNDRED GRAMS] per Pharmacy Bulk Package Bag
  • FOR INTRAVENOUS USE ONLY
  • NOT TO BE DISPENSED AS A UNIT
  • Rx Only
  • Sterile, Nonpyrogenic, Preservative-Free
  • Each 100 gram Pharmacy Bulk Package contains sterile ceftriaxone sodium equivalent to 100 grams of ceftriaxone. The sodium content is 83 mg (3.6 mEq) per gram of ceftriaxone activity.
  • Use this formulation only in patients who require a 1 gram dose. Contains 100 doses (1 gram per dose). See package insert. USUAL DOSAGE: See package insert.
  • Prior to reconstitution, store dry powder at 20u00b0 to 25u00b0C (68u00b0 to 77u00b0F). [See USP Controlled Room Temperature]n- 4 HOURS
  • THIS PHARMACY BULK PACKAGE IS INTENDED FOR PREPARING MANY SINGLE DOSES IN A PHARMACY ADMIXTURE PROGRAM.
  • See package insert for detailed reconstitution, final dilution, and administration instructions.
  • PROTECT FROM LIGHT. THE INNER BAG SHOULD BE RETAINED IN THE OUTER BAG UNTIL TIME OF USE.
  • SmartPak system components are not made with natural rubber latex.
  • Manufactured forn n

Ask for Quote

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler, Supplier, Exporters from India of Ceftriaxone Sodium (Ceftriaxone) which is also known as Ceftriaxone and Manufactured by Samson Medical Technologies, LLC. It is available in strength of 100 g/1.

Ceftriaxone Sodium (Ceftriaxone) is supplied for Tenders, Emergency imports, Un - licensed, Specials, Orphan drug, Name patient line, RLD supplies, Reference listed drugs, Comparator Drug, Bio-Similar, Innovator samples, For Clinical trials. Click to know price.

Browse Our Services And Processes

Name Patient Supply

Name Patient Supply

Validated Cold Chain Shipment

Validated Cold Chain Shipment

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

Our Process - The Gnh Way

Our Process - The Gnh Way

Other Pharmaceutical Products

BENZALKONIUM CHLORIDE - 1 (nickelodeon bright bubble gum scented hand sanitizer)

BENZALKONIUM CHLORIDE - 1 (nickelodeon bright bubble gum scented hand sanitizer)

Liposomal Amphotericin - B for Injection IP (AmBisome)

Liposomal Amphotericin - B for Injection IP (AmBisome)

Edatate Calcium Disodium Injection USP 200mg/ml (Cal-Rsodate)

Edatate Calcium Disodium Injection USP 200mg/ml (Cal-Rsodate)

Melphalan Injection IP 50mg (Alkacel)

Melphalan Injection IP 50mg (Alkacel)

Monobenzone Cream USP 20% (Albaquin)

Monobenzone Cream USP 20% (Albaquin)

Beclomethasone Dipropionate and Levosalbutamol Inhaler (Aerocort)

Beclomethasone Dipropionate and Levosalbutamol Inhaler (Aerocort)

Are you an existing customer or a vendor of GNH India? Log in here to